Clinical trial
Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back…
NCT00237341 · PriCara, Unit of Ortho-McNeil, Inc., Industry · Completed
Key facts
| NCT number | NCT00237341 |
|---|---|
| Title | Duragesic® (Fentanyl Transdermal System) Functionality Trial in Chronic Low Back Pain |
| Official title | Assessing Functionality Changes Associated With Patients Who Were Taking Short Acting Opioids Chronically and Who Initiated Treatment With Duragesic® (Fentanyl Transdermal System) for the Management of Chronic Low Back Pain. |
| Lead sponsor | PriCara, Unit of Ortho-McNeil, Inc., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Low Back Pain |
| Intervention type | Drug |
| Interventions | fentanyl |
| Enrollment | 358 |
| Start date | Jun 1, 2002 |
| Completion | Jan 1, 2004 |
| First posted | Oct 12, 2005 |
| Last update posted | Nov 20, 2013 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: